Opthea Limited announced the appointment of Judith Robertson as the company's first Chief Commercial Officer (CCO), effective January 1, 2022. Concurrently with this appointment, Robertson has stepped down as a non-executive member of the company's board of directors, a position she has held since June 2021, to pursue the full-time executive CCO role. Judith Robertson is an accomplished life sciences commercial executive with an extensive track record for building, leading and launching several commercial organizations.

Prior to joining the company, Robertson was most recently Chief Commercial Officer of Eleusis Ltd. and was previously Chief Commercial Officer of Aerie Pharmaceuticals. Prior to Aerie, Robertson was Global Commercial Vice President Immunology and Ophthalmology at Johnson and Johnson, Janssen Pharmaceuticals, and Global Vice President Ophthalmology at Novartis (formerly Alcon). Her prior experience also includes several senior executive commercial roles at Searle and Bristol Myers Squibb including President and General Manager of Bristol Myers Squibb Canada.